Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_assertion type Assertion NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_head.
- NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_assertion description "[We investigated genetically affected leukemic cells in FIP1L1-PDGFRA+ chronic eosinophilic leukemia (CEL) and in BCR-ABL1+ chronic myeloid leukemia (CML), two myeloproliferative disorders responsive to imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_provenance.
- NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_assertion evidence source_evidence_literature NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_provenance.
- NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_assertion SIO_000772 17215855 NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_provenance.
- NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_assertion wasDerivedFrom befree-20150227 NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_provenance.
- NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_assertion wasGeneratedBy ECO_0000203 NP613590.RAlezckk4Z1rtJTodr8KCDFpEcVNocieqimq6bayK_YMA130_provenance.